Big changes are in store for one of Britain’s most prestigious universities if, as expected, University College London signs off on a modernising green paper from Provost Malcolm Grant.
Galapagos NV is bolstering its ability to select drug targets and compounds by acquiring Inpharmatica Ltd in an all-share transaction that values the UK bioinformatics company at €12.5 million.